BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2018
View Archived Issues
Positive data presented from SEQUOIA and CEDAR phase III studies of abicipar
Read More
Transgenic mouse model useful to study the hypersensitivity reactions of abacavir
Read More
Phase IIa study of BT-063 for the treatment of SLE meets primary endpoint
Read More
Gritstone Oncology to test GRANITE-001 with Opdivo and Yervoy
Read More
Membrane findings point to new antimalarial strategies
Read More
Sending live phages after deadly lung infections
Read More
The Yang to KRAS' Yin?
Read More
First biomarker for liver injury from biologic
Read More
AT: all bad for platelets
Read More
Aevi presents AEVI-004, novel co-crystal version of AEVI-001
Read More
UCT-943, a next-generation PI4K inhibitor antimalarial agent: Preclinical profile
Read More
Wakamoto completes phase II trial of WP-1303
Read More
BeiGene reports preliminary phase II topline data for tislelizumab in classical Hodgkin's lymphoma
Read More
FDA grants approval to Tibsovo for relapsed/refractory AML with IDH1 mutation
Read More
UCB Pharma divulges UDP/CysLT receptor modulators
Read More
Researchers find IL-6 levels tied to worse prognosis in ESCC patients
Read More
New G protein-coupled receptor 39 agonists patented by Daiichi Sankyo
Read More
INSERM and collaborators describe lactic acid bacteria compositions
Read More
Samsung Life Public Welfare Foundation creates siRNAs specific to the SS18-SSX fusion gene
Read More
ShanghaiTech University synthesizes PIWIL4 inhibitors
Read More
New phase I study evaluates MK-4830 alone and with pembrolizumab for advanced solid tumors
Read More
FDA approves single-dose Krintafel for radical cure of P. vivax malaria
Read More
Asceneuron presents phase I results for ASN-120290
Read More
